DWA
HBIO icon

Dorsey Wright & Associates’s Harvard Bioscience HBIO Stock Holding History

Dorsey Wright & Associates’s Portfolio HBIO Stock Details HBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-396
Closed -$17K – 195
2023
Q3 		$17K Sell
396
-14
-3% -$646 0.01% 276
2023
Q2 		$22.5K Buy
+410
New +$22.5K 0.01% 239
2022
Q1 		– Sell
-774
Closed -$55K – 309
2021
Q4 		$55K Buy
774
+105
+16% +$7.47K 0.01% 222
2021
Q3 		$47K Buy
669
+52
+8% +$4.14K 0.01% 220
2021
Q2 		$51K Buy
+617
New +$43.6K 0.01% 188

Other funds holding HBIO

2C
272 Capital Dallas, Texas $40M AUM 150.07% 1-Year Est. Return
PAIM
Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HP
Harvey Partners Tarrytown, New York $1.26B AUM 64.44% 1-Year Est. Return
AE
AMH Equity Great Neck, New York $80.3M AUM 78.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Dorsey Wright & Associates's HBIO Position: Q4 2023 in Review

Dorsey Wright & Associates sold out of Harvard Bioscience (HBIO) in Q4 2023, closing a stake of 396 shares — an estimated $17K sold.

Dorsey Wright & Associates first reported a position in HBIO in Q2 2021 and held it in 5 quarters. The position peaked at $55K in Q4 2021. 93 funds tracked by Wall St. Rank hold HBIO as of Q4 2023.

  • Dorsey Wright & Associates reported no remaining Harvard Bioscience position as of Q4 2023 after selling out during the quarter.
  • Dorsey Wright & Associates sold 396 Harvard Bioscience shares in Q4 2023, an estimated $17K.
  • Dorsey Wright & Associates first reported a position in Harvard Bioscience in Q2 2021 and held it in 5 quarters.
  • Dorsey Wright & Associates's Harvard Bioscience position peaked at $55K in Q4 2021.
  • 93 funds tracked by Wall St. Rank held Harvard Bioscience as of Q4 2023.

Based on Dorsey Wright & Associates's 13F filing for Q4 2023, filed 13 Feb 2024.